经肌性腰方肌阻滞与胸椎旁阻滞用于腹腔镜肾脏手术后急性疼痛及恢复质量:随机对照试验研究方案
本研究为前瞻性、随机、单中心、开放标签、平行三臂非劣效性试验,拟纳入120例腹腔镜肾切除术患者,比较经肌性腰方肌阻滞(TMQLB)两种剂量方案与胸椎旁阻滞(TPVB)的术后镇痛效果,主要结局为术后24小时平均VAS评分,旨在为TMQLB的镇痛机制及腹腔镜肾脏手术应用提供临床证据。
要点
- 拟纳入120例腹腔镜肾切除术患者,随机分为TMQLB组1、TMQLB组2和TPVB对照组。
- TMQLB组1和TPVB对照组均使用0.4 ml/kg体重0.5%罗哌卡因,TMQLB组2使用0.6 ml/kg体重0.5%罗哌卡因。
- 主要结局为TMQLB组1与TPVB组术后24小时平均VAS疼痛评分的差异。
核心结论
- 本试验旨在为阐明TMQLB的镇痛机制及其在腹腔镜肾脏手术中的应用提供重要临床证据。
研究设计与样本
- 前瞻性、随机、单中心、开放标签、平行三臂非劣效性试验,拟纳入120例腹腔镜肾切除术患者。
- 术前随机分为三组:TMQLB实验组1(0.4 ml/kg体重0.5%罗哌卡因)、TMQLB实验组2(0.6 ml/kg体重0.5%罗哌卡因)或TPVB对照组(0.4 ml/kg体重0.5%罗哌卡因,于T10椎体处)。
主要发现
- 术后48小时内通过静脉患者自控镇痛(IPCA)给予吗啡,单次剂量1.5~2 mg。
- 主要结局为TMQLB组1与TPVB组术后24小时平均VAS疼痛评分的差异。
- 次要结局包括TMQLB组2与TPVB组术后24小时平均VAS评分的差异、累积吗啡用量、长期疼痛控制、感觉丧失皮节分布、恶心评分、瘙痒评分、下床活动时间、肠蠕动恢复时间、恢复质量、术后住院时间及患者对麻醉的满意度。
- 还将总结操作相关并发症的安全性数据。
关键数值与推荐
- 排除标准包括:对麻醉药过敏、注射部位感染、凝血功能障碍或使用抗凝药、因慢性疾病使用镇痛药、有药物滥用史或存在沟通障碍。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Quadratus lumborum block (QLB) is increasingly gaining popularity as a novel abdominal truncal block in abdominal surgery; however, the mechanism of QLB is not yet thoroughly illustrated. The focus of our study is transmuscular QLB (TMQLB), as the latest anatomical evidence shows that anesthetics spread into the thoracic paravertebral space to exert an analgesic effect. Therefore, we designed this study to compare TMQLB with thoracic paravertebral block (TPVB) in laparoscopic renal surgery in the hope of providing clinical evidence on the analgesic mechanism of TMQLB and its application in laparoscopic renal surgery. METHODS: This trial is a prospective, randomized, single-center, open-label, parallel, three-arm, non-inferiority trial. We intend to include 120 participants undergoing laparoscopic nephrectomy and before surgery they will be randomized into three groups for postoperative pain control: TMQLB experimental group 1 (0.4 ml/kg body weight 0.5% ropivacaine), TMQLB experimental group 2 (0.6 ml/kg body weight 0.5% ropivacaine) or TPVB control group (0.4 ml/kg body weight 0.5% ropivacaine at vertebra T10). Patients will be excluded if they have allergy to anesthetics, infection at the injection site, are on coagulopathy or anticoagulants, on analgesics for chronic illness, have history of substance abuse or have a barrier to communication. Morphine is given in boluses of 1.5~2 mg by intravenous patient-controlled analgesia (IPCA) in the first 48 h after surgery. The primary outcome is the difference between TMQLB group 1 and the TPVB group in the mean visual analogue scale (VAS) pain score in the first 24 h after surgery. Secondary outcomes are the difference between TMQLB group 2 and the TPVB group in the mean VAS score in the first 24 h after surgery, cumulative morphine consumption, long-term pain control, dermatomal distribution of sensory loss, nausea score, pruritus score, ambulation time, time till recovery of bowel movement, quality of recovery, postoperative length of hospital stay and patient satisfaction with anesthesia. Safety data on procedure-related complications will also be summarized. DISCUSSION: This will the first randomized controlled trial to compare TMQLB with TPVB for analgesia in laparoscopic surgery. This trial aims to provide important clinical evidence to elaborate on the analgesic mechanism of TMQLB. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03414281 . Registered on 9 January 2018.
引用
- Yuan Q, Cui X, Fei Y, et al. Transmuscular quadratus lumborum block versus thoracic paravertebral block for acute pain and quality of recovery after laparoscopic renal surgery: study protocol for a randomized controlled trial. Trials. 2019. PMID: 31109368. doi:10.1186/s13063-019-3359-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。